ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 169 filers reported holding ALLAKOS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,535 | -42.9% | 171,161 | +9.6% | 0.01% | -40.0% |
| Q2 2023 | $681,019 | +1011.1% | 156,197 | +1034.0% | 0.02% | +1400.0% |
| Q1 2023 | $61,294 | -36.8% | 13,774 | +19.6% | 0.00% | -50.0% |
| Q4 2022 | $96,956 | +185.2% | 11,515 | +7.2% | 0.00% | +100.0% |
| Q2 2022 | $34,000 | -85.4% | 10,745 | -54.9% | 0.00% | -80.0% |
| Q4 2021 | $233,000 | -90.0% | 23,800 | +8.1% | 0.01% | -92.2% |
| Q3 2021 | $2,332,000 | +64.3% | 22,026 | +32.4% | 0.06% | +42.2% |
| Q2 2021 | $1,419,000 | +274.4% | 16,630 | +403.9% | 0.04% | +221.4% |
| Q1 2021 | $379,000 | +70.7% | 3,300 | +6.9% | 0.01% | -6.7% |
| Q2 2020 | $222,000 | -88.1% | 3,088 | -87.0% | 0.02% | -91.2% |
| Q3 2019 | $1,863,000 | – | 23,688 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |